AstraZeneca to publish full U.S. trial results after rebuke over 'outdated' data

AstraZeneca will publish up-to-date results from its major U.S. COVID-19 vaccine trial within 48 hours after health officials publicly criticized the drugmaker for using "outdated information" to show…